PROFUSA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
PROFUSA, INC. (PFSA) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $50.00 per share as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2026-08-19
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $50.00.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $0.35.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $0.35.
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $11.50.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price |
|---|---|
| 2026-06-30 | $50.00 10-Q · filed 2026-08-19 |
| 2025-12-31 | $0.35 S-1/A · filed 2026-05-01 |
| 2025-09-30 | $0.35 10-Q · filed 2025-11-19 |
| 2023-09-30 | $11.50 10-Q · filed 2023-11-20 |
| 2023-06-30 | $11.50 10-Q · filed 2023-08-14 |
| 2023-03-31 | $11.50 10-Q · filed 2023-05-17 |
| 2022-12-31 | $11.50 10-Q · filed 2023-11-20 |
| 2022-09-30 | $11.50 10-Q · filed 2022-11-10 |
| 2022-06-30 | $11.50 10-Q · filed 2022-08-11 |
| 2022-03-31 | $11.50 10-Q · filed 2022-05-12 |
| 2021-12-31 | $11.50 10-K · filed 2023-03-06 |
| 2021-12-22 | $11.50 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |